Regenerative Therapy

807 papers and 7.2k indexed citations i.

About

The 807 papers published in Regenerative Therapy in the last decades have received a total of 7.2k indexed citations. Papers published in Regenerative Therapy usually cover Molecular Biology (301 papers), Surgery (269 papers) and Genetics (196 papers) specifically the topics of Mesenchymal stem cell research (189 papers), Tissue Engineering and Regenerative Medicine (137 papers) and Pluripotent Stem Cells Research (110 papers). The most active scholars publishing in Regenerative Therapy are Jun Takahashi, Yasuhiko Tabata, Masayuki Yamato, Yueh‐Hsun Yang, Edward Hosea Ntege, Hiroshi Sunami, Yusuke Shimizu, Teruo Okano, Goshi Shiota and Shu Guo.

In The Last Decade

Fields of papers published in Regenerative Therapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Regenerative Therapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Regenerative Therapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Regenerative Therapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Regenerative Therapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025